The historical rank and industry rank for Mercanto Holdings's Net Margin % or its related term are showing as below:
TSXV:MUSH'
s Net Margin % Range Over the Past 10 Years
Min: -1590.5 Med: -14.29 Max: 1.05
Current: -5.11
TSXV:MUSH's Net Margin % is ranked worse than 72.91% of 956
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs TSXV:MUSH: -5.11
Mercanto Holdings (TSXV:MUSH) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Mercanto Holdings Net Margin % Related Terms
Mercanto Holdings Net Margin % Historical Data
* Premium members only.
The historical data trend for Mercanto Holdings's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Mercanto Holdings's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Mercanto Holdings Net Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Mercanto Holdings's Net Margin % distribution charts can be found below:
* The bar in red indicates where Mercanto Holdings's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mercanto Holdings (TSXV:MUSH) has a Net Margin % of 9.20% as of Jan. 2026. Net margin is the ratio of total net income to net sales. View historical data on Mercanto Holdings and its competitors. According to the industry distribution chart, Mercanto Holdings ranks #697 out of 956 companies in the Drug Manufacturers industry, placing it in the top 72.9%.
Is Mercanto Holdings' Net Margin % too high?
Mercanto Holdings' current Net Margin % is 9.20%. The Drug Manufacturers industry median Net Margin % is 5.56. Mercanto Holdings' value of 9.20% is 65.5% above this industry median. Based on the distribution chart, Mercanto Holdings ranks #697 out of 956 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Mercanto Holdings has a GF Score™ of 32/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Mercanto Holdings' Net Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Mercanto Holdings ranks #697 out of 956 companies for Net Margin %. This places Mercanto Holdings in the lower half of its industry. The industry median Net Margin % is 5.56. Mercanto Holdings' value of 9.20% is 65.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 956 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Mercanto Holdings's current Net Margin % of 9.20% is 65.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Mercanto Holdings and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Mercanto Holdings's current Net Margin % is 9.20%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Mercanto Holdings stock overvalued right now?
Based on GuruFocus' analysis, Mercanto Holdings (TSXV:MUSH) is currently considered Fairly Valued. The stock's GF Value™ is C$0.14, compared to a current price of C$0.13 — trading 7.1% below its estimated fair value. The current Net Margin % is 9.20% and 65.5% above the Drug Manufacturers industry median of 5.56. Mercanto Holdings' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Mercanto Holdings (TSXV:MUSH), the current Net Margin % is 9.20% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Mercanto Holdings (TSXV:MUSH) Overvalued in 2026?
Based on GuruFocus' analysis, Mercanto Holdings stock appears to be undervalued.
The current stock price of C$0.13 is trading 7.1% below its estimated GF Value™ of C$0.14.
GuruFocus considers Mercanto Holdings to be Fairly Valued.
Key valuation signals for TSXV:MUSH:
Net Margin %: 9.20%
GF Value™: C$0.14 vs. price of C$0.13 (7.1% below fair value)
Industry Position: 65.5% above the Drug Manufacturers median (#697 of 956)
No single metric tells the full story. See the TSXV:MUSH stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Mercanto Holdings Inc operates a portfolio of brands that include traditional cannabis and beverage products. The company exists to promote the use of mushrooms through its brands; The company offers quality products that promote health, recreation, and well-being. The portfolio of the company includes different cannabis products, probiotic, functional mushroom beverages, and others.
32GF Score
Get the complete analysis for TSXV:MUSH
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSXV:MUSH has been successfully added to your 
